The Leukemia & Lymphoma Society of Canada
Caroline Horcher is an experienced communications professional with a diverse background in strategic communications, writing, media relations, and event planning. Currently serving as Direct Marketing Lead and Campaign Communications Lead at The Leukemia & Lymphoma Society of Canada since August 2021, Caroline also operates as a Freelance Communications Specialist for various organizations, including ONpoint Strategy Group and the Heart and Stroke Foundation, since June 2009. Previous roles include Senior Manager of Communications and Operations at RevGen Professional Fundraising, Manager of Public Affairs at FP Canada, and Communications Manager at SickKids Centre for Community Mental Health. Caroline's career began with the Multiple Sclerosis Society of Canada, where significant contributions were made in marketing and fundraising. Caroline holds a Bachelor of Arts Degree with a double major in Economics and Psychology, a Public Relations Diploma, and a Digital Marketing Certificate, all from reputable institutions.
This person is not in any teams
The Leukemia & Lymphoma Society of Canada
The Leukemia & Lymphoma Society of Canada (LLSC) is a voluntary health agency dedicated to blood cancer. LLSC funds lifesaving blood cancer research across Canada and worldwide, and provides free information and support services. We won’t stop until there is a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms and are able to improve the quality of life of people affected by blood cancers and their families by funding life-enhancing research and providing educational resources, services and support. Our strategy to achieve the mission is based on three areas of focus: research, patient support and advocacy. In 2017, we invested almost $7.4 million in the creation of programs and delivery of services to improve the lives of Canadians affected by blood cancers from coast to coast. This investment included a commitment of over $4.1 million in innovative, life-changing research to accelerate new cancer treatments, therapies, and cures; and $3.3 million towards funding patient services, programs and education across Canada. Everything we do is made possible through the generosity of individuals, corporate partners, and foundations. In the last two decades alone, the Leukemia & Lymphoma Society of Canada has raised $207 million for research and services. We receive no government support.